US Patent Issued to Eyebio Korea on Sept. 30 for "Peptide compound or pharmaceutically acceptable salt thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,446, issued on Sept. 30, was assigned to Eyebio Korea (Busan, South Korea).

"Peptide compound or pharmaceutically acceptable salt thereof" was invented by Yoo Seok Kim (Gyeonggi-do, South Korea), Myoung Hwan Kim (Gyeonggi-do, South Korea), Young In Kim (Gyeonggi-do, South Korea), Taek Joo Lim (Gyeonggi-do, South Korea), Hyeong Joon Lim (Gyeonggi-do, South Korea), Jee Young Kim (Busan, South Korea) and Eun Young Park (Busan, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel peptide compound or a pharmaceutically acceptable salt thereof."

The patent was filed on May 20, 2020, under Application No. 17...